Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.